Cargando…

Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature

SIMPLE SUMMARY: Gene expression monotonicity is an important feature in the evolution and progression of cancer, yet has not been investigated in bladder cancer (BLCA). Most of the transcriptomic stage investigations of BLCA are limited either to a subset of stages, or to a small number of samples....

Descripción completa

Detalles Bibliográficos
Autores principales:	Stroggilos, Rafael, Frantzi, Maria, Zoidakis, Jerome, Mokou, Marika, Moulavasilis, Napoleon, Mavrogeorgis, Emmanouil, Melidi, Anna, Makridakis, Manousos, Stravodimos, Konstantinos, Roubelakis, Maria G., Mischak, Harald, Vlahou, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140126/ https://www.ncbi.nlm.nih.gov/pubmed/35626146 http://dx.doi.org/10.3390/cancers14102542

Ejemplares similares

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
por: Latosinska, Agnieszka, et al.
Publicado: (2017)

Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness
por: Lygirou, Vasiliki, et al.
Publicado: (2022)

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
por: Mokou, Marika, et al.
Publicado: (2020)

BcCluster: A Bladder Cancer Database at the Molecular Level
por: Bhat, Akshay, et al.
Publicado: (2016)

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease
por: Mokou, Marika, et al.
Publicado: (2019)

Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma
por: Makridakis, Manousos, et al.
Publicado: (2020)

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of –omics findings
por: Latosinska, Agnieszka, et al.
Publicado: (2016)

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca(2+) signaling in T24M-based bladder cancer models
por: Frantzi, Maria, et al.
Publicado: (2016)

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
por: Frantzi, Maria, et al.
Publicado: (2023)

Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration
por: Zagoura, Dimitra, et al.
Publicado: (2019)

Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease
por: Tserga, Aggeliki, et al.
Publicado: (2022)

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation
por: Latosinska, Agnieszka, et al.
Publicado: (2020)

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023)

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis
por: Latosinska, Agnieszka, et al.
Publicado: (2015)

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
por: Lygirou, Vasiliki, et al.
Publicado: (2018)

Reviewing the Regulators of COL1A1
por: Devos, Hanne, et al.
Publicado: (2023)

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment
por: Lohia, Sonnal, et al.
Publicado: (2023)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells
por: Roubelakis, Maria G, et al.
Publicado: (2011)

Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies A Novel Proteomic Signature
por: Nicolaides, Nicolas C., et al.
Publicado: (2022)

Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions
por: Frantzi, Maria, et al.
Publicado: (2017)

Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018)

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)

The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I
por: Mavridis, George, et al.
Publicado: (2021)

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation
por: Chatziharalambous, Despina, et al.
Publicado: (2016)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

Urinary peptide panel for prognostic assessment of bladder cancer relapse
por: Krochmal, Magdalena, et al.
Publicado: (2019)

Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Insights into Biomechanical and Proteomic Characteristics of Small Diameter Vascular Grafts Utilizing the Human Umbilical Artery
por: Mallis, Panagiotis, et al.
Publicado: (2020)

Short Term Results of Fibrin Gel Obtained from Cord Blood Units: A Preliminary in Vitro Study
por: Mallis, Panagiotis, et al.
Publicado: (2019)

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine
por: Filip, Szymon, et al.
Publicado: (2015)

PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016)

A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease
por: Catanese, Lorenzo, et al.
Publicado: (2021)

Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2022)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018)

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
por: Lohia, Sonnal, et al.
Publicado: (2022)

Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD
por: Hobson, Sam, et al.
Publicado: (2023)

Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis
por: Kontostathi, Georgia, et al.
Publicado: (2017)

In Situ Peroxidase Labeling Followed by Mass-Spectrometry Reveals TIA1 Interactome
por: Gourdomichali, Olga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4is9grtd54mgehbctns9uass2